These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20332417)

  • 1. Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient.
    Basic-Jukic N; Kes P; Bubic-Filipi L; Vranjican Z
    Nephrol Dial Transplant; 2010 Jun; 25(6):2036; author reply 2036-7. PubMed ID: 20332417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statin-induced rhabdomyolysis and renal failure: also with fluvastatine].
    Lado Lado FL; Rodríguez Moreno C; Cinza Sajurjo S; Durán Parrondo C; Pazo Núñez M; Lois Pernas A; Masa Vázquez L
    An Med Interna; 2004 May; 21(5):235-7. PubMed ID: 15176926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe rhabdomyolysis associated with concurrent use of simvastatin and sirolimus after cisplatin-based chemotherapy in a kidney transplant recipient.
    Hong YA; Kim HD; Jo K; Park YK; Lee J; Sun IO; Chung BH; Park CW; Yang CW; Choi BS
    Exp Clin Transplant; 2014 Apr; 12(2):152-5. PubMed ID: 23734754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin, rhabdomyolysis, and myotoxicity.
    Murinson BB; Maragakis NJ; Jacobson TA
    Mayo Clin Proc; 2008 Nov; 83(11):1296; author reply 1297. PubMed ID: 18990330
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.
    Atasoyu EM; Evrenkaya TR; Solmazgul E
    Ann Pharmacother; 2005; 39(7-8):1368-9. PubMed ID: 15956236
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.
    Baek SD; Jang SJ; Park SE; Ok TJ; Leem J; Lee HS; Park SJ; Kim TH
    J Korean Med Sci; 2011 Dec; 26(12):1634-7. PubMed ID: 22148003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hypercholesterolemia in kidney transplant recipients].
    Fritsche L; Budde K; Neumayer HH
    Dtsch Med Wochenschr; 2003 Apr; 128(16):879-81. PubMed ID: 12701034
    [No Abstract]   [Full Text] [Related]  

  • 8. [High therapeutic effect and safety of fluvastatin].
    Pharm Unserer Zeit; 2003; 32(6):516-7. PubMed ID: 14639833
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins.
    Forestier F; Breton Y; Bonnet E; Janvier G
    Anesthesiology; 2002 Oct; 97(4):1019-21. PubMed ID: 12357176
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential warfarin-fluvastatin interaction.
    Kline SS; Harrell CC
    Ann Pharmacother; 1997 Jun; 31(6):790. PubMed ID: 9184730
    [No Abstract]   [Full Text] [Related]  

  • 11. The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
    S Afr Med J; 2002 Aug; 92(8):596-7. PubMed ID: 12244613
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial.
    Serón D; Oppenheimer F; Pallardó LM; Lauzurica R; Errasti P; Gomez-Huertas E; Bosmans JL; Sanchez-Plumed J; Romero R; Marques M; Fulladosa X; Moreso F
    Transplantation; 2008 Jul; 86(1):82-7. PubMed ID: 18622282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lichenoid drug eruption with HMG-CoA reductase inhibitors (fluvastatin and lovastatin).
    Sebök B; Tóth M; Anga B; Harangi F; Schneider I
    Acta Derm Venereol; 2004; 84(3):229-30. PubMed ID: 15202842
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis secondary to hyponatraemia.
    Lara Aguayo P; de la Fuente Martos C; Morán Fernández E; Soriano Rodríguez F; Rojas Amezcua M; Aguilar Alonso E
    Nefrologia; 2011; 31(4):500-2. PubMed ID: 21738260
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluvastatin and cancer.
    Mascitelli L; Pezzetta F
    Int J Clin Pract; 2007 Jan; 61(1):168; author reply 168-9. PubMed ID: 17229191
    [No Abstract]   [Full Text] [Related]  

  • 16. Increases in creatine kinase after exercise in patients treated with HMG Co-A reductase inhibitors.
    Thompson PD; Nugent AM; Herbert PN
    JAMA; 1990 Dec; 264(23):2992. PubMed ID: 2243421
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.
    Holdaas H; Fellström B; Cole E; Nyberg G; Olsson AG; Pedersen TR; Madsen S; Grönhagen-Riska C; Neumayer HH; Maes B; Ambühl P; Hartmann A; Staffler B; Jardine AG;
    Am J Transplant; 2005 Dec; 5(12):2929-36. PubMed ID: 16303007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe colchicine intoxication in a renal transplant recipient on cyclosporine.
    Garrouste C; Philipponnet C; Kaysi S; Enache I; Tiple A; Heng AE
    Transplant Proc; 2012 Nov; 44(9):2851-2. PubMed ID: 23146540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Woman Experienced Severe Thrombocytopenia When Treated With Fluvastatin].
    Potier A; Dony A; Crapsky A; Ferry O; Piney D; Dufay E
    Therapie; 2015; 70(6):541-4. PubMed ID: 26238127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.